Similar articles

• Human IL-32 expression protects mice against a hypervirulent strain of Mycobacterium tuberculosis.

  Bai X, Shang S, Henao-Tamayo M, Basaraba RJ, Ovrutsky AR, Matsuda JL, Takeda K, Chan MM, Dakhama A, Kinney WH, Trostel J, Bai A, Honda JR, Achcar R, Hartney J, Joosten LA, Kim SH, Orme I, Dinarello CA, Ordway DJ, Chan ED. Bai X, et al. Proc Natl Acad Sci U S A. 2015 Apr 21;112(16):5111-6. doi: 10.1073/pnas.1424302112. Epub 2015 Mar 27. Proc Natl Acad Sci U S A. 2015. PMID: 25820174 Free PMC article.
• [Protective immunity against Mycobacterium tuberculosis].

  Kawamura I. Kawamura I. Kekkaku. 2006 Nov;81(11):687-91. Kekkaku. 2006. PMID: 17154048 Review. Japanese.
• Tuberculosis vaccine promises sterilizing immunity.

  McShane H, Williams A. McShane H, et al. Nat Med. 2011 Oct 11;17(10):1185-6. doi: 10.1038/nm.2503. Nat Med. 2011. PMID: 21988991 No abstract available.
• Influence of diabetes mellitus on immunity to human tuberculosis.

  Kumar Nathella P, Babu S. Kumar Nathella P, et al. Immunology. 2017 Sep;152(1):13-24. doi: 10.1111/imm.12762. Epub 2017 Jun 29. Immunology. 2017. PMID: 28543817 Free PMC article. Review.
• Early secretory antigenic target-6 of Mycobacterium tuberculosis: enigmatic factor in pathogen-host interactions.

  Chandra Rai R, Dwivedi VP, Chatterjee S, Raghava Prasad DV, Das G. Chandra Rai R, et al. Microbes Infect. 2012 Nov;14(13):1220-6. doi: 10.1016/j.micinf.2012.07.019. Epub 2012 Aug 9. Microbes Infect. 2012. PMID: 22909901 Review.